arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

PRECISION OPTICS CORPORATION, INC.

POCI
$4.22 ▼ -0.02 (-0.47%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
15 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
26
Health
Poor
Moderately Bearish
auto_awesome

Analytical Summary

PRECISION OPTICS CORPORATION, INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). On the positive side, Debt to Equity remains strong. Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $28.7M
Dividend Yield
Revenue Growth -0.1%
Op. Margin -29.1%
ROIC -39.1%
FCF / Share $-0.56
Trailing P/E
Price / Book 2.7x
FCF Yield
Debt / Equity 0.16
info Valuation on last close. End-of-day price, Aug 7, 2026.

15-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$19.09M
— -0.1%
Net Income Profit after all expenses
$-5.78M
↓ -95.8%
Operating Margin Operating profit as % of sales
-29.1%
↓ -103.9% 8th
FCF / Share Free cash flow per share
$-0.56
↓ -14.1%
Long-Term Debt Long-term obligations
$1.93M
↑ +1.6%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
8
Returns
17
Financial Health
49
Cash Quality
46

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 64 quarters